Get started
Author

Kirsty Taylor

Observed names: K Taylor, K. Taylor
Observed institutions: Queen's University Belfast, University Health Network, University of Toronto, Princess Margaret Cancer Centre, Belfast City Hospital, The Northern Ireland Cancer Centre
ORCID: 0000-0003-1715-3890
Observed ORCID: 0000-0003-1715-3890
OpenAlex ID: A5059486986
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
2020 · Kirsty Taylor, Helen Loo Yau, et al. · Journal for ImmunoTherapy of Cancer · 74
PDF
Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy
2022 · Giselle M. Boukhaled, Ramy Gadalla, et al. · Nature Immunology · 56
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study)
2021 · Marc Oliva, Pierre H. H. Schneeberger, et al. · British Journal of Cancer · 48
PDF
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients
2023 · Kirsty Taylor, Jinfeng Zou, et al. · European Journal of Cancer · 38
PDF
Combined 18F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer
2022 · Reut Anconina, Claudia Ortega, et al. · Clinical Nuclear Medicine · 33
Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma
2020 · Lucy X. Ma, Kirsty Taylor, et al. · Cancer Medicine · 24
PDF
Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer
2021 · Reut Anconina, Claudia Ortega, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 20
PDF
Inflammatory fibroid polyp of the ileum causing recurrent intussusception and chronic ischaemia: a case report
2008 · Anna M O'Kane, Mark E O'Donnell, et al. · Cases Journal · 15
PDF
Role of the oral and gut microbiota as a biomarker in locoregionally advanced oropharyngeal squamous cell carcinoma (ROMA LA-OPSCC).
2019 · Marc Oliva Bernal, Pierre H.H. Schneeberger, et al. · Journal of Clinical Oncology · 8
Prognostic significance of malnutrition in metastatic esophageal squamous cell carcinoma.
2019 · Kirsty Taylor, Osvaldo Espin-Garcia, et al. · Journal of Clinical Oncology · 8
Efficacy Considerations in Phase I Trials
2020 · Kanan Alshammari, Kirsty Taylor, et al. · Springer eBooks · 5
Innovation and Advances in Precision Medicine in Head and Neck Cancer
2021 · Geoffrey Alan Watson, Kirsty Taylor, et al. · Springer eBooks · 3
PDF
Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma.
2020 · Lucy Xiaolu Ma, Kirsty Taylor, et al. · Journal of Clinical Oncology · 3
Management Approaches in WHO Grade III Meningioma: A National Oncology Trainees' Collaborative for Healthcare Research (NOTCH) UK Multi-Centre Retrospective Study
2024 · C.B. Dobeson, M. Baxter, et al. · Clinical Oncology · 2
PDF
Personalized circulating tumor DNA (ctDNA) analysis in patients with recurrent/metastatic head and neck squamous cell cancer (R/M HNSCC).
2022 · Kirsty Taylor, Jinfeng Zou, et al. · Journal of Clinical Oncology · 2
Radiomic response evaluation of recurrent or metastatic head and neck squamous cell cancer (R/M HNSCC) patients receiving pembrolizumab on KEYNOTE-012 study.
2020 · Kirsty Taylor, Michal Kazmierski, et al. · Journal of Clinical Oncology · 2
NG11-2 phase-Ib trial to prevent/reduce severe oral mucositis induced by radiotherapy.
2025 · Mary Lei, Rafael Moleron, et al. · Journal of Clinical Oncology · 1
PDF
Real world outcomes in cancer patients with COVID-19 infection: Northern Ireland experience.
2023 · Laura Feeney, Ashleigh Hamilton, et al. · PubMed Central · 1
PDF
Impact of body measurements (BM) on overall survival (OS) and quality of life (QoL) in real-world patients (pts) with metastatic esophageal cancer.
2020 · Joelle Soriano, Katrina Hueniken, et al. · Journal of Clinical Oncology · 1
Impact of sarcopenia and adiposity in survival of metastatic esophageal cancer (MEC)
2019 · A.F. Fares, K. Taylor, et al. · Annals of Oncology · 1
Abstract CT190: A Phase II basket study of hypomethylating agent oral cc-486 and durvalumab in advanced solid tumors (METADUR)
2019 · Kirsty Taylor, Helen Loo Yau, et al. · Cancer Research · 1
Abstract CT190: A Phase II basket study of hypomethylating agent oral cc-486 and durvalumab in advanced solid tumors (METADUR)
2019 · Kirsty Taylor, Helen Loo Yau, et al. · Clinical Trials · 1
124 Neo-adjuvant/peri-operative chemo-immunotherapy for resectable early stage Non-Small Cell Lung Cancer: a review of patients treated in Northern Ireland (NI) September 2023–November 2025
2026 · Edwina Johnston, Rand Al-bahlawan, et al. · Lung Cancer
1463: NG11-2 Phase Ib trial to reduce radiation-induced oral mucositis on patients with head & neck cancer
2024 · Mary Lei, Rafael Moleron, et al. · Radiotherapy and Oncology
886P Circulating tumor DNA kinetics in recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC) patients
2021 · K. Taylor, J. Zou, et al. · Annals of Oncology
PDF
Works count: 30
Citation count: 347
H-index: 8
I10-index: 8
Year
Topic
Type